Synthetic biology has created oscillators, latches, logic gates, logarithmically linear circuits, and load drivers that have electronic analogs in living cells. The ubiquitous operational amplifier, which allows circuits to operate robustly and precisely has not been built with biomolecular parts. As in electronics, a biological operational-amplifier could greatly improve the predictability of circuits despite noise and variability, a problem that all cellular circuits face. Here, we show how to create a synthetic 3-stage inducer-input operational amplifier with a differential transcription-factor stage, a CRISPR-based push-pull stage, and an enzymatic output stage with just 5 proteins including dCas9. Our 'Bio-OpAmp' expands the toolkit of fundamental circuits available to bioengineers or biologists, and may shed insight into biological systems that require robust and precise molecular homeostasis and regulation.
Ideas from analog circuits and feedback theory are increasingly being appreciated as very important in synthetic and systems biology (11, (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) . We discuss two examples that are useful for providing some motivation for our work.
A quorum-sensing molecule has been used to increase the production of a cell killing molecule such that attenuations in the fluctuations of a microbial population result (20) . Such a circuit is an example of a clever negative-feedback loop that achieves some population control in living cells. However, it does not use an operational amplifier with a user-programmable population set-point to achieve precise population control. Thus, the circuit would not be robust to disturbances in the quorum sensing molecule concentration. As another example, prior 'load driver' circuits in cells have used an elegant phosphor-relay system to create large production and degradation fluxes at their outputs, which are inherently fast, such that relatively small loading fluxes, which are inherently slow, do not significantly impact their operation (10) . Thus, a 'molecular buffer circuit' can be created. However, it does not use an operational amplifier with global negative feedback around all its gain stages to achieve high feedback loop strength. Thus, unlike true operational-amplifier topologies, it does not allow for robust closed-loop programmable gain, is not insensitive to nonlinearities from its input to output, and cannot provide good buffering capability at low output flux.
Figures 1a, 1b, and 1c illustrate our three-gain-stage biological operational amplifier (Bio-OpAmp) as a conceptual block diagram, as it is implemented in cells with molecular parts, and as a circuit schematic respectively. The first gain stage is a fast-differential stage with arabinose and AHL inducer inputs that generate two corresponding sgRNA outputs. The second gain stage is a slow differential stage that uses CRISPR-sgRNA complexes to produce AiiA and LuxI enzyme outputs. The third gain stage is a fast stage that uses AiiA and LuxI enzymes to help degrade or increase AHL concentration respectively (2) . The AiiA and LuxI enzymes also perform differential-to-single-input conversion to regenerate the AHL input as an output such that a negative feedback loop is created. In this negative-feedback loop, arabinose then effectively serves as a control or set-point inducer input that determines the intended equilibrium and homeostatically-controlled value of the output inducer AHL. Since protein (green) production is relatively slow, but RNA (red) and inducer (purple) production are fast, the negative-feedback loop inherently has a dominantly slow protein time constant corresponding to LuxI/AiiA degradation. This dominant time constant naturally promotes stability even under strong negative feedback (12) , much like that of a dominant integrator time constant in well-known operationalamplifier or biological feedback configurations in chemotaxis (17) .
The CRISPR-based parts in Figure 1b were constructed by modifying a plasmid used in other circuits (25) . The CRISPR system was selected mainly because dCas9 can be programmed to bind almost any chromosome locus with a PAM recognition site with high specificity and because RNA dynamics are fast. Even though the feedback loop strength is determined by three gain stages and is therefore relatively large, the short life time of sgRNA (26) and AHL in our system compared with the long-life time of LuxI and AiiA naturally alleviate oscillation and instability. Such multi-gain-stage amplifiers, are otherwise, prime candidates for oscillation (12) as for example in repressor cascades with negative feedback (1) . Figure 1c is useful in mapping our biological circuit schematic to electronic circuit schematics that quantitatively and pictorially model and represent the production (diamond current-producing generators), degradation (rectangular current-consuming resistors) or state preservation (horizontal-parallel-line capacitors) of molecular species in coupled differential equations with DNA (blue), RNA (red), protein (green), or small-molecule inducers (purple) (14) . Current generation at DNA promoters is either constitutive (circular current generator) or dependent on another control variable (diamond current generator with an arrow input). Figure 1c reveals that because, dCas9 is a fixed resource, whose molecule number is regulated by ATc/TetR, its binding or consumption by one half of the circuit, i.e., by sgRNA1, leads to less of it being available to bind to the other half of the circuit, i.e., by sgRNA2. Thus, there is fast coupling between the two halves of the operational amplifier that effectively serves to increase its gain. Others have also exploited the sharing of a common resource to benefit their synthetic circuits via fast coupling as well (2) . In our case, the sharing of dCas9 in the Bio-OpAmp effectively serves to increase gain via 'push-pull' amplification. A push-pull effect is exploited in the output stages of many electronic operational amplifiers to improve their performance as well (12) . circuits, P1-rfp and P2-rfp, were implemented as three-plasmid systems. In the high copy number plasmid (HCN), sgRNA1 is controlled by a constitutively expressed LuxR (27) while sgRNA2 is controlled by AraC (28) respectively. The dCas9 shared-resource pool is controlled by TetR (29) and ATc (anhydrotetracycline).
Even though arabinose does not effectively connect to the repressed output in Figure 2a as AHL does, at relatively high concentrations, it competes for dCas9 as a 'decoy'. Thus, it leads to de-repression and increase of the AHL-controlled RFP output in Figure 2b (Figures 2b and 2d) . Nevertheless, as the biological data of Figure 3 The output AHL was measured via the proxy rfp molecule as shown (Supplementary Figure S1) .
We tested the full Bio-OpAmp by combining strains with P1-luxI circuits and strains with P2-aiiA circuits in a common co culture (details are described in materials and methods). The closed-loop amplification can then be programmably and conveniently varied by varying the cell numbers in these two populations. It also alleviates synthetic-circuit metabolic burden in each cell as in several other practicable synthetic-circuit schemes (2, 3, 8, 30) . Finally, it could enable a modular design for our Bio-OpAmp that can be ported by others to cellular circuits with different consortia and parts in a molecular-homeostasis application of their choosing. Supplementary Table S2 suggests a few examples. Figure 3b reveal that the output AHL faithfully tracks the input arabinose over more than an order of magnitude of input dynamic range as would be expected in a high-performance control system with negative feedback. Furthermore, Figure 3b also shows that the operational amplifier is robust to intentionally induced initial disturbance inputs of AHL over more than two orders of magnitude, always rejecting these disturbances such that the final measured AHL output (or its proxy rfp) only tracks the arabinose input. Figure 3c shows that a model of the Bio-OpAmp based on Figure 1c , which is described in more detail in the Supplementary section, yields results very near that measured experimentally in Figure 3b .
Measured experimental data in
Supplementary Figure 2 shows that, in a control experiment where there is no synthetic negativefeedback operational amplifier present, the disturbance AHL input is not rejected such that the final AHL output concentration is simply proportional to the disturbance AHL concentration, and does not track the arabinose input. Figure 3d shows that the gain (output rfp variation for a given variation in arabinose) varies when the ratio of P1-luxI to P2-aiiA varies from 1:5 to 5:1 in the Bio-OpAmp such that userprogrammable closed-loop gain can be implemented. In our case, a nearly 10-fold change in output results for low arabinose concentrations and different plasmid (or cell-population) ratios. Figure 3 arises because of the logarithmically linear biochemical potential variation in analog circuits and analog computation in cells (9, (12) (13) (14) . Homeostasis is a universal phenomenon wherein biological systems maintain steady states of output variables rejecting disturbances from external conditions (11, 17, 19) . Bacterial iron homeostasis, plasma-ionized calcium homeostasis, and human blood glucose homeostasis provide but a few examples (21) (22) (23) . In biology, just as in our synthetic circuit, two different molecules compete via two different halves of a negative-feedback loop (21) (22) (23) to arrange molecular homeostasis. For example, blood glucose homeostasis in the body, which malfunctions in diabetes, is implemented through two half circuits related to insulin-releasing  cells in the pancreas and glucagon-releasing  cells in the pancreas (21, 22) . Hence, our synthetic circuit with the AHL and arabinose halves has similar analogs in nature.
Logarithmically linear operation in
Our Bio-OpAmp circuit motif may be useful in molecular homeostasis in biotechnology and medicine. In Table S2 in the supplementary, we suggest how Bio-OpAmps in different cell types can be designed with different molecular parts pertinent to the cell or application but with the same circuit architecture. For example, in technologies that utilize microbes to produce industrially important molecules like succinic-acid, toxicity or substrate inhibition from intermediate metabolites or final products is one of the reasons that bacterial growth is inhibited (24, 31) . A Bio-OpAmp can enable precise control of such metabolites.
Over nearly two decades, others have shown that logic-gate circuit motifs can be ported Here, arabinose represses P2-rfp, while AHL de-represses it analogous to the effects described in a and b. 
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